Keyword: generic drugs

News

Swedish Drugmaker Meda Spurns Mylan Approach

07.04.2014 - Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion. Reports said Mylan was exploring a bid at...

Plant Construction & Process Technology

Duloxetine: Refining its Chemical Synthesis with Biocatalysis

09.03.2014 - Competing With Generics - With product innovation falling and drugs going off patent, the generic pharmaceutical market is becoming more predominant. It is expected that generics...

News

Actavis to Buy Forest Labs for $25 billion

21.02.2014 - Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...

News

German Generics Producers Charge Discrimination

11.02.2014 - German generic drugmakers are annoyed at plans by the new Christian and Social Democrat coalition government to increase the mandatory rebate afforded the country's national...

News

Merkel Seen to Stop German Drug Legislation

17.12.2013 - German chancellor Angela Merkel has intervened to stop the introduction of new pharmaceuticals legislation planned by the new grand coalition of her Christian Democrat party (CDU)...

News

Boehringer Unit Taps Bank of America to Explore Sale of Generics Business

04.12.2013 - Ben Venue Laboratories, a Bedford, Ohio-based subsidiary of German drugmaker Boehringer Ingelheim has tapped Bank of America Merrill Lynch to explore a possible sale of its generic...

Plant Construction & Process Technology

Standing Out in Global Pharmaceutical Contract Manufacturing Market

12.11.2013 - Joining The Supply Chain - Pharmaceutical contract manufacturing used to be viewed as a one-off activity where a pharmaceutical company outsourced a drug for manufacturing...

Plant Construction & Process Technology

Rethinking Biosimilar Development

08.11.2013 - The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...